Pharmerging: Global Strategic Business Report

Global Pharmerging Market to Reach $3.1 Billion by 2030

The global market for Pharmerging estimated at US$1.5 Billion in the year 2022, is projected to reach a revised size of US$3.1 Billion by 2030, growing at a CAGR of 9.9% over the analysis period 2022-2030. Pharmaceutical, one of the segments analyzed in the report, is projected to record 8.4% CAGR and reach US$1.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Healthcare segment is readjusted to a revised 12.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $430.4 Million, While China is Forecast to Grow at 9.3% CAGR

The Pharmerging market in the U.S. is estimated at US$430.4 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$540.9 Million by the year 2030 trailing a CAGR of 9.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.6% and 8.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR.

Select Competitors (Total 22 Featured) -

• Abbott Laboratories
• AbbVie, Inc.
• Alexion Pharmaceuticals, Inc.
• Allergan PLC
• Amgen, Inc.
• Aspen Pharmacare Holdings Ltd.
• Astellas Pharma, Inc.
• AstraZeneca PLC
• Baxter International, Inc.
• Bayer AG
• Biogen, Inc.
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Company
• Celgene Corporation
• CSL Behring
• Daiichi Sankyo Co., Ltd.
• Eisai Co., Ltd.
• Eli Lilly and Company
• Endo International PLC
• F. Hoffmann-La Roche AG
• GlaxoSmithKline PLC
• Grifols SA
• H. Lundbeck A/S
• Hospira, Inc.
• Johnson & Johnson
• Kyowa Hakko Kirin Co., Ltd.
• Mallinckrodt Pharmaceuticals
• Mitsubishi Tanabe Pharma Corporation
• Mylan Pharmaceutical Pvt. Ltd.
• Novartis AG
• Novo Nordisk A/S
• Otsuka Pharmaceutical Co., Ltd.
• Pfizer, Inc.
• Sanofi SA
• Shire PLC
• Stada Arzneimittel AG
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Co., Ltd.
• Teva Pharmaceutical Industries Ltd.
• UCB SA

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year